Comparison · Neuromodulators
Daxxify vs. Botox: Duration Claims vs. Reality
| Attribute | Daxxify DaxibotulinumtoxinA-lanm | Botox Cosmetic OnabotulinumtoxinA | Dysport AbobotulinumtoxinA | Xeomin IncobotulinumtoxinA |
|---|---|---|---|---|
| FDA approval (cosmetic) | 2022 (glabellar lines) | 2002 (glabellar lines) | 2009 (glabellar lines) | 2011 (glabellar lines) |
| Stabilizer | Proprietary peptide (no albumin) | Human serum albumin | Human serum albumin | No accessory proteins ('naked' toxin) |
| Onset | 2–3 days | 3–5 days | 2–3 days | 3–4 days |
| Trial-reported median duration | ~6 months (SAKURA, at trial threshold) | ~3–4 months | ~3–4 months | ~3–4 months |
| Typical real-world duration | 4–6 months (variable) | 3–4 months | 3–4 months | 3–4 months |
| Dose unit equivalence | Roughly 1:1 vs. Botox at glabella per label | Reference | ~2.5–3 Dysport units per 1 Botox unit | Roughly 1:1 vs. Botox |
| Typical glabellar dose | 40 units | 20 units | 50 units | 20 units |
| Cost per session (glabella) | $600–$1,000+ | $300–$600 | $300–$600 | $300–$550 |
The duration claim
What the SAKURA Trial Actually Showed
Daxxify's headline 6-month duration comes from the SAKURA pivotal trials. Median duration of effect at the trial's defined response threshold (glabellar line severity ≥1-point improvement on validated scales) was reported around 6 months. At the more stringent threshold of return to none/mild lines, duration was closer to ~4 months.
The marketing claim isn't fabricated — but the threshold matters. Patients whose mental model of 'still working' is closer to the stricter endpoint will experience shorter real-world durability than the headline number.
Real-world durability
What Patients Actually Experience
In practice, the duration distribution is wide. Some patients reliably get 6 months from Daxxify; others get 4–5; a meaningful minority get the same ~3–4 months they got from Botox at equivalent dose.
Factors that compress duration in any neuromodulator: lower dose, more active muscle (athletic, expressive patient), faster metabolism, and prior antibody formation in patients who have had years of albumin-stabilized product.
A reasonable expectation for an average patient at adequate dosing: 4–5 months from Daxxify, 3–4 months from Botox, Dysport, Xeomin, or Jeuveau.
Cost math
Cost Per Month of Coverage
At typical pricing, Daxxify per session costs roughly 1.5–2x Botox. If a patient's real-world Daxxify duration is 5 months and Botox is 4 months, cost-per-month is similar to slightly higher for Daxxify.
The math favors Daxxify only when the real duration extends meaningfully beyond what the patient gets from a standard neuromodulator — and only the patient's actual prior history can confirm that.
When Daxxify makes sense
When a Dermatologist Recommends Daxxify
- ·Patients with documented short Botox duration (3 months or less) who want a longer interval.
- ·Patients with established antibodies or reduced response to albumin-stabilized products.
- ·Patients who travel and want fewer touch-ups per year.
- ·Patients willing to accept higher per-session cost in exchange for longer interval.
When Botox makes sense
When Botox (or Dysport / Xeomin / Jeuveau) Is the Better Default
- ·New neuromodulator patients with no historical baseline.
- ·Patients sensitive to early-onset or 'too long' results — shorter duration allows faster adjustment if the result isn't ideal.
- ·Preventative-dose patients in their 20s and early 30s who want shorter intervals and lower dose.
- ·Cost-conscious patients or those who like the option of trying the off-label small areas (lip flip, masseter) at lower per-unit pricing.
Frequently asked
Common questions
Does Daxxify really last 6 months?
The SAKURA pivotal trial supported median duration around 6 months at the trial's defined response threshold; real-world durability is variable, often 4–5 months in everyday practice.
Is Daxxify stronger than Botox?
Not stronger per unit — the glabellar label dose is 40 units of Daxxify vs. 20 of Botox. Duration is the marketed differentiator, not intensity.
Is Daxxify safe?
Yes, with the same general safety profile and contraindications as other neuromodulators. Same standard risks: bruising, asymmetry, eyelid ptosis, headache.
Can I switch from Botox to Daxxify?
Yes — there is no washout requirement. A dermatologist can convert your existing dosing pattern to a Daxxify-equivalent dose.
Which is best for first-time patients?
Botox or one of the other established neuromodulators. Shorter duration lets you assess the result and adjust dose; Daxxify locks you into a longer commitment to your first dose.
References
Sources
- 1.Daxxify (daxibotulinumtoxinA-lanm) Prescribing Information — Revance Therapeutics / U.S. FDA, 2022.
- 2.SAKURA 1 and SAKURA 2 Pivotal Trials of DaxibotulinumtoxinA for Glabellar Lines — JAMA Dermatology, 2022.
- 3.Botox Cosmetic (onabotulinumtoxinA) Prescribing Information — Allergan / U.S. FDA, 2024.
Related